Immunogen, Inc. (IMGN) Misses Q4 EPS by 51c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. IVBIY

Go back to Immunogen, Inc. (IMGN) Misses Q4 EPS by 51c

Immunogen (IMGN) Remains Neutral Rated at UBS

August 4, 2014 9:49 AM EDT

UBS maintained a Neutral rating on Immunogen Inc. (NASDAQ: IMGN) with a modified price target of $11.00 (from $13.00). Comments follow Q4 results. Analyst Andrew Peters said he was still waiting to see data from ASCO.

"While FY2015 revenue guidance came in meaningfully... More